BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32277801)

  • 1. Acute lymphoblastic leukemia clonal distribution between bone marrow and peripheral blood.
    Fries C; Adlowitz DG; Spence JM; Spence JP; Rock PJ; Burack WR
    Pediatr Blood Cancer; 2020 Jun; 67(6):e28280. PubMed ID: 32277801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen receptor sequencing of paired bone marrow samples shows homogeneous distribution of acute lymphoblastic leukemia subclones.
    Theunissen PMJ; van Zessen D; Stubbs AP; Faham M; Zwaan CM; van Dongen JJM; Van Der Velden VHJ
    Haematologica; 2017 Nov; 102(11):1869-1877. PubMed ID: 28860343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High throughput sequencing in acute lymphoblastic leukemia reveals clonal architecture of central nervous system and bone marrow compartments.
    Bartram J; Goulden N; Wright G; Adams S; Brooks T; Edwards D; Inglott S; Yousafzai Y; Hubank M; Halsey C
    Haematologica; 2018 Mar; 103(3):e110-e114. PubMed ID: 29217777
    [No Abstract]   [Full Text] [Related]  

  • 4. Clonal evolution as judged by immunoglobulin heavy chain gene rearrangements in relapsing precursor-B acute lymphoblastic leukemia.
    Rosenquist R; Thunberg U; Li AH; Forestier E; Lönnerholm G; Lindh J; Sundström C; Sällström J; Holmberg D; Roos G
    Eur J Haematol; 1999 Sep; 63(3):171-9. PubMed ID: 10485272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myeloma.
    Rustad EH; Misund K; Bernard E; Coward E; Yellapantula VD; Hultcrantz M; Ho C; Kazandjian D; Korde N; Mailankody S; Keats JJ; Akhlaghi T; Viny AD; Mayman DJ; Carroll K; Patel M; Famulare CA; Op Bruinink DH; Hutt K; Jacobsen A; Huang Y; Miller JE; Maura F; Papaemmanuil E; Waage A; Arcila ME; Landgren O
    Am J Hematol; 2019 Dec; 94(12):1364-1373. PubMed ID: 31571261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical perspective on immunoglobulin heavy chain clonal heterogeneity in B cell acute lymphoblastic leukemia.
    Fries C; Burack WR
    Leuk Res; 2018 Dec; 75():15-22. PubMed ID: 30445235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of clonal immunoglobulin gene rearrangements in the PBPC harvests of patients with acute lymphoblastic leukaemia.
    Owen RG; Johnson RJ; Evans PA; Smith GM; Child JA; Morgan GJ
    Bone Marrow Transplant; 1995 Dec; 16(6):831-4. PubMed ID: 8750277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimal residual disease in acute lymphoblastic leukaemia--PCR analysis of immunoglobulin gene rearrangements.
    Cole-Sinclair M; Foroni L; Wright F; Mehta A; Prentice HG; Hoffbrand AV
    Leuk Lymphoma; 1993; 11 Suppl 2():49-58. PubMed ID: 8124233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of minimal residual disease levels in bone marrow and peripheral blood in adult acute lymphoblastic leukemia.
    Kotrova M; Volland A; Kehden B; Trautmann H; Ritgen M; Wäsch R; Faul C; Viardot A; Schwartz S; Baldus CD; Gökbuget N; Brüggemann M
    Leukemia; 2020 Apr; 34(4):1154-1157. PubMed ID: 31641191
    [No Abstract]   [Full Text] [Related]  

  • 10. Profile of immunoglobulin heavy chain variable gene repertoires and highly selective detection of malignant clonotypes in acute lymphoblastic leukemia.
    Greenberg SJ; Choi Y; Ballow M; Du TL; Ward PM; Rickert MH; Frankel S; Bernstein SH; Brecher ML
    J Leukoc Biol; 1995 Jun; 57(6):856-64. PubMed ID: 7790768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput sequencing in acute lymphoblastic leukemia: Follow-up of minimal residual disease and emergence of new clones.
    Salson M; Giraud M; Caillault A; Grardel N; Duployez N; Ferret Y; Duez M; Herbert R; Rocher T; Sebda S; Quief S; Villenet C; Figeac M; Preudhomme C
    Leuk Res; 2017 Feb; 53():1-7. PubMed ID: 27930944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expansion of polyclonal B-cell precursors in bone marrow from children treated for acute lymphoblastic leukemia.
    Duval M; Fenneteau O; Cave H; Gobillot C; Rohrlich P; Guidal C; Lescoeur B; Legac S; Schlegel N; Sterkers G; Vilmer E
    Hematol Cell Ther; 1997 Jun; 39(3):139-47. PubMed ID: 9262991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular detection and characterization of clonal cell populations in acute lymphocytic leukemia by analysis of conformational polymorphisms of cRNA molecules of rearranged T-cell-receptor-gamma and immunoglobulin heavy-chain genes.
    Koch OM; Volkenandt M; Göker E; Buer J; Probst M; Banerjee D; Danenberg PV; Bertino JR
    Leukemia; 1994 Jun; 8(6):946-52. PubMed ID: 8207989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competitive PCR for quantification of minimal residual disease in acute lymphoblastic leukaemia.
    Nyvold C; Madsen HO; Ryder LP; Seyfarth J; Engel CA; Svejgaard A; Wesenberg F; Schmiegelow K
    J Immunol Methods; 2000 Jan; 233(1-2):107-18. PubMed ID: 10648861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PCR detection of clonal IgH and TCR gene rearrangements at the end of induction as a non-remission criterion in children with ALL: comparison with standard morphologic analysis and risk group classification.
    Scrideli CA; Queiroz RG; Bernardes JE; Valera ET; Tone LG
    Med Pediatr Oncol; 2003 Jul; 41(1):10-6. PubMed ID: 12764736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of detection of monoclonality in remission marrow in acute lymphoblastic leukemia in childhood. Australian and New Zealand Children's Cancer Study Group.
    Brisco MJ; Condon J; Hughes E; Neoh SH; Nicholson I; Sykes PJ; Tauro G; Ekert H; Waters K; Toogood I
    Leukemia; 1993 Oct; 7(10):1514-20. PubMed ID: 8412313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in immunoglobulin heavy chain gene rearrangmeent patterns between bone marrow and blood samples in childhood precursor B-acute lymphoblastic leaukemia at diagnosis.
    Beishuizen A; Verhoeven MA; Hählen K; van Wering ER; van Dongen JJ
    Leukemia; 1993 Jun; 7(6):60-3. PubMed ID: 8315958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group.
    Cavé H; van der Werff ten Bosch J; Suciu S; Guidal C; Waterkeyn C; Otten J; Bakkus M; Thielemans K; Grandchamp B; Vilmer E
    N Engl J Med; 1998 Aug; 339(9):591-8. PubMed ID: 9718378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic leukemia: evidence for the persistence of a preleukemic clone.
    Konrad M; Metzler M; Panzer S; Ostreicher I; Peham M; Repp R; Haas OA; Gadner H; Panzer-Grumayer ER
    Blood; 2003 May; 101(9):3635-40. PubMed ID: 12506024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common clonal origin of an acute B-lymphoblastic leukemia and a Langerhans' cell sarcoma: evidence for hematopoietic plasticity.
    Ratei R; Hummel M; Anagnostopoulos I; Jähne D; Arnold R; Dörken B; Mathas S; Benter T; Dudeck O; Ludwig WD; Stein H
    Haematologica; 2010 Sep; 95(9):1461-6. PubMed ID: 20421277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.